Role of the data safety and monitoring board in an international trial

被引:0
|
作者
Caceres, Carlos F.
Coates, Thomas J.
Hartwell, Tyler D.
Kasprzyk, Danuta
Kelly, Jeffrey A.
Kozlov, Andrei P.
Pequegnat, Willo
Rotheram-Borus, Mary Jane
Solomon, Suniti
Woelk, Godfrey
Wu, Zunyou
机构
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[4] St Petersburg State Univ, Biomed Ctr, St Petersburg, Russia
[5] NIMH, Bethesda, MD 20892 USA
[6] Univ Zimbabwe, Sch Med, Harare, Zimbabwe
[7] Yale Univ, New Haven, CT 06520 USA
[8] Stanford Univ, Stanford, CA 94305 USA
[9] Univ Calif San Francisco, San Francisco Dept Publ Hlth, San Francisco, CA 94143 USA
[10] Miriam Hosp, Providence, RI 02906 USA
[11] Univ N Carolina, Chapel Hill, NC 27515 USA
[12] SAHAI Trust, Madras, Tamil Nadu, India
[13] Natl Ctr STD & Leprosy Control, Nanjing, Peoples R China
[14] Univ Arizona, Tucson, AZ 85721 USA
关键词
community popular opinion leader; data safety and monitoring board; sexually transmitted diseases; HIV;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To describe the composition and role of the data safety and monitoring board (DSMB) for the National Institute of Mental Health (NIMH) Collaborative HIV/STD Prevention Trial. Design: NIMH appointed to the DSMB nine members representing the following areas of expertise: prevention science, ethnography, infectious diseases (especially HIV and sexually transmitted diseases), laboratory diagnostics, clinical practice, methodology, international trial experience, statistics, and ethics. Methods: The DSMB assessed the overall study for any concern about plans or implementation and reviewed cumulative study data to evaluate the safety of study participants, the ongoing conduct of the study, and the scientific validity and integrity of the Trial. Because of the Trial's international scope, the DSMB examined the effects of cultural differences on study implementation and fidelity. Results: Among the DSMB recommendations that strengthened the Trial was one to conduct initial epidemiological studies of the venues selected for the intervention to verify risk and to establish intraclass correlation coefficients that could be used to calculate appropriate sample sizes. Conclusions: The DSMB played a critical role in this Trial. Because members have the expertise required to monitor the Trial, are not involved in the daily management of the Trial, and can review interim analyses and adverse event reports, they are in an excellent position to provide expert advice to ensure that the Trial's goals are achieved and that NIH funds are well invested. (C) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:S99 / S102
页数:4
相关论文
共 50 条
  • [21] The role of external evidence in data monitoring of a clinical trial
    Pocock, SJ
    STATISTICS IN MEDICINE, 1996, 15 (12) : 1285 - 1293
  • [22] Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT
    Bristow, Michael R.
    Sharma, Kavita
    Assmann, Susan F.
    Linas, Stuart
    Gersh, Bernard J.
    Grady, Christine
    Rice, Madeline Murguia
    Singh, Steven
    Boineau, Robin
    McKinlay, Sonja M.
    Greenberg, Barry H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (04) : 457 - 465
  • [23] Data safety and monitoring board in non-industry trials: learning it the hard way
    Hazenberg, A.
    Kerstjens, H. A. M.
    Wijkstra, P. J.
    RESPIRATORY RESEARCH, 2015, 16
  • [24] The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials
    DeMets, DL
    Fleming, TR
    Whitley, RJ
    Childress, JF
    Ellenberg, SS
    Foulkes, M
    Mayer, KH
    OFallon, J
    Pollard, RB
    Rahal, JJ
    Sande, M
    Straus, S
    Walters, L
    WhitleyWilliams, P
    CONTROLLED CLINICAL TRIALS, 1995, 16 (06): : 408 - 421
  • [25] Meeting the Need: A Training Course for Data Safety Monitoring Board (DSMB) Members in LMIC
    Black, S.
    Sturkenboom, M.
    DRUG SAFETY, 2022, 45 (10) : 1151 - 1152
  • [26] “Data safety and monitoring board in non-industry trials: learning it the hard way”
    A. Hazenberg
    H. A. M. Kerstjens
    P. J. Wijkstra
    Respiratory Research, 16
  • [27] Impact of Data Safety Monitoring Board quality on clinical trials safety management: analysis of non-conformity
    Ricard, N.
    Nguon, M.
    Lapeyre, M.
    Bodenan, E.
    Robinson, P.
    Blanc, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 40 - 40
  • [28] The role of data and safety monitoring in acute trauma resuscitation research
    Champion, Howard R.
    Fingerhut, Abe
    Escobar, Miguel A.
    Weiskopf, Richard B.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (01) : 73 - 83
  • [29] CLINICAL-TRIAL DATA AND SAFETY MONITORING BOARDS - THE SEARCH FOR A CONSTITUTION
    ARMSTRONG, PW
    FURBERG, CD
    CIRCULATION, 1995, 91 (03) : 901 - 904
  • [30] Enhancing clarity of clinical trial safety reports for data monitoring committees
    Thomas, Sonia M.
    Jung, Kwanhye
    Sun, Hengrui
    Psioda, Matthew A.
    Quibrera, Pedro Miguel
    Strakowski, Stephen M.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (06) : 1147 - 1161